The Central government has decided that from January 2015 all regulated drugs will show 'DPCO Scheduled Drug' label in black ink on a bold red strip and their ceiling price per unit, an official source said. "The proposal under consideration is ... MedIndia, 1 week ago
2 images for "dpco"
Even as the paucity of the life saving drug human albumin serum has been persisting for the past several months in retail and hospital pharmacies, Maharashtra FDA has confiscated drugs worth Rs. 1.5 lakh from a Mumbai based stockist Nexus Lifecare ...PharmaBiz, 1 week ago Kerala facing acute shortage of albumin serum, liver disease patients in distress PharmaBiz, 3 weeks ago Human albumin serum not available across India post NPPA price cut PharmaBiz, 2 months ago
The Centre today told the Delhi High Court that if luxury condoms are removed from the Drug Price Control Order (DPCO) then the manufacturers will flood the market with their expensive variety and make their lesser priced contraceptives scarce. The ...Business Standard, 2 weeks ago Firms may flood market with luxury condoms if price cap removed: HC told Millennium Post, 2 weeks ago Pharma firms may flood market with luxury condoms if price cap removed: Centre to HC Economic Times, 2 weeks ago
Some time ago, a Drug Price Control Order (DPCO) had substantially brought down the prices of many essential and life-saving drugs, to the immense relief of the suffering public. But the National Pharmaceutical Pricing Authority (NPPA) suddenly ...The Echo Of India, 4 weeks ago Govt Plans to Check Overpricing of Life-saving Drugs International Business Times India, 1 week ago Pharmaceutical companies refute Congress' post claiming hike in prices of life-saving drugs Economic Times, 1 month ago Post on Cong site stirs up frenzy over drug prices Economic Times, 1 month ago
The drug regulator, in an earlier notification, had invoked Paragraph 19 of DPCO, 2013 to bring 108 anti-diabetic and cardiovascular formulation packs under the price control. (Photo: PTI/File) New Delhi: The Supreme Court on Monday refused to ...Deccan Chronicle, 1 month ago Supreme Court not to Interfere in Drug Prices New Indian Express, 1 month ago Decontrolling drug prices: SC refuses to interfere Hindustan Times, 1 month ago SC won't interfere in decontrolling price The Week, 1 month ago
The Maharashtra Food and Drug Administration (FDA) has recommended to the Drug Controller General of India (DCGI) and National Pharmaceutical Pricing Authority (NPPA) to bring five categories of medical devices like Neuro Coils, Cochlear Implants, ...PharmaBiz, 1 month ago Maha FDA files FIR against 4 persons for illegal stock, sales of prescription drugs PharmaBiz, 2 months ago State FDA serves notices on 13 wholesalers for non-compliance to D&C Rules PharmaBiz, 1 month ago
Regulating prices of patented drugs marketed in the country is an issue dragging on with no decision forthcoming for the last several years. Although the Indian Patent Act was amended in 2005, the government has been attempting to bring some control ...PharmaBiz, 1 month ago Decontrolling Drug Prices Peoples Democracy.in, 1 month ago Why price control of drugs by the National Pharmaceutical Pricing Authority is important DNA, 1 month ago ATTEMPT TO WEAKEN NPPA PharmaBiz, 1 month ago
More from: Myiris, India TV...and 9 other sources
If the Government keeps a close watch over diesel prices, air fares and even mobile phone tariffs, why doesn't it do something about the spiralling prices of medicines? If that's your question, it does through the Drug (Pricing Control) Order ...Hindu Business Line, 1 month ago
"The prices have been fixed / revised in respect of 43 formulation packs, both ceiling and retail price packs, under DPCO, 2013," NPPA said. NEW DELHI: National Pharmaceutical Pricing Authority (NPPA) has capped the prices of 43 formulation packs including ...Economic Times, 2 months ago New NPPA notification on 43 formulations to hit sales by 33% and trade margin by 6% PharmaBiz, 2 months ago Prices of 43 More Drugs Capped New Indian Express, 2 months ago Indian Pharma regulator cuts prices of 43 drug formulations Domain-B, 2 months ago
More from: , Hindu Business Line...and 4 other sources
Angel Broking's report on Sanofi India "Sanofi India (Sanofi)'s 3QCY2014 results have come in below expectations both on the top-line and bottom-line front. The company posted sales of Rs 487cr (V/s an expected Rs 530cr), ie a yoy growth of 3.1%.Moneycontrol.com, 1 day ago Sanofi India 3QCY2014 performance highlights and results update Stock Markets Review, 1 week ago
on your WebpageAdd Widget >Get your members hooked!